Antibiotic resistance during and beyond COVID-19

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Public Health Policy

Background:

• Antibiotics are crucial for modern medicine and life expectancy, creating vulnerable elderly populations disproportionately affected by the COVID-19 pandemic.
• Government responses to COVID-19, including lockdowns and healthcare refocusing, have significant implications for antibiotic resistance patterns.
• The pandemic highlighted the interplay between public health measures, healthcare system strain, and the evolution of antimicrobial resistance.

Purpose of the Study:

• To analyze the multifaceted implications of the COVID-19 pandemic on antibiotic resistance.
• To explore how different pandemic control strategies and vaccine outcomes may shape future antibiotic use and resistance.
• To project the long-term effects on hospital antibiotic consumption and the emergence of nosocomial infections.

Main Methods:

• Review of healthcare system responses during the COVID-19 pandemic, including changes in intensive care unit (ICU) stewardship and overall antibiotic use.
• Analysis of the potential impact of non-pharmaceutical interventions (NPIs) like travel restrictions and social distancing on the transmission of resistant bacteria.
• Modeling future scenarios based on vaccine efficacy, potential for prolonged NPIs, and the possibility of 'living with the virus'.

Main Results:

• During early COVID-19, relaxed ICU stewardship may have promoted resistance, while decreased hospital antibiotic use reduced selection pressure.
• Reduced travel and social distancing potentially limited community spread of resistant bacteria, though data are scarce.
• Future antibiotic resistance is contingent on vaccine success; failure scenarios may increase outpatient use of long half-life antibiotics and post-pandemic hospital workloads.

Conclusions:

• The COVID-19 pandemic has complex and sometimes contradictory effects on antibiotic resistance.
• Vaccine development is pivotal in determining the trajectory of antibiotic resistance post-pandemic.
• Increased hospital activity and patient backlogs post-pandemic are likely to drive higher antibiotic use and resistance, necessitating new antimicrobial agents.